Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import

J Cell Sci. 2015 Nov 15;128(22):4151-9. doi: 10.1242/jcs.176602. Epub 2015 Sep 24.

Abstract

Aberrant cytoplasmic aggregation of FUS, which is caused by mutations primarily in the C-terminal nuclear localisation signal, is associated with 3% of cases of familial amyotrophic lateral sclerosis (ALS). FUS aggregates are also pathognomonic for 10% of all frontotemporal lobar degeneration (FTLD) cases; however, these cases are not associated with mutations in the gene encoding FUS. This suggests that there are differences in the mechanisms that drive inclusion formation of FUS in ALS and FTLD. Here, we show that the C-terminal tyrosine residue at position 526 of FUS is crucial for normal nuclear import. This tyrosine is subjected to phosphorylation, which reduces interaction with transportin 1 and might consequentially affect the transport of FUS into the nucleus. Furthermore, we show that this phosphorylation can occur through the activity of the Src family of kinases. Our study implicates phosphorylation as an additional mechanism by which nuclear transport of FUS might be regulated and potentially perturbed in ALS and FTLD.

Keywords: Amyotrophic lateral sclerosis; FUS; Frontotemporal lobar degeneration; Nuclear import; Phosphorylation; Transportin 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Amino Acid Sequence
  • Amyotrophic Lateral Sclerosis / metabolism
  • Frontotemporal Lobar Degeneration / metabolism
  • HeLa Cells
  • Humans
  • Molecular Sequence Data
  • Phosphorylation
  • RNA-Binding Protein FUS / metabolism*
  • Tyrosine / genetics
  • Tyrosine / metabolism*
  • beta Karyopherins / metabolism

Substances

  • FUS protein, human
  • RNA-Binding Protein FUS
  • TNPO1 protein, human
  • beta Karyopherins
  • Tyrosine

Supplementary concepts

  • Amyotrophic lateral sclerosis 1